Hussman Strategic Advisors Inc. boosted its position in HCA Healthcare Inc (NYSE:HCA) by 51.6% during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 75,800 shares of the company’s stock after buying an additional 25,800 shares during the period. HCA Healthcare makes up about 1.5% of Hussman Strategic Advisors Inc.’s investment portfolio, making the stock its 8th largest position. Hussman Strategic Advisors Inc.’s holdings in HCA Healthcare were worth $6,610,000 at the end of the most recent reporting period.

Several other institutional investors have also recently bought and sold shares of the company. Janney Montgomery Scott LLC boosted its position in HCA Healthcare by 0.4% in the second quarter. Janney Montgomery Scott LLC now owns 3,174 shares of the company’s stock worth $277,000 after buying an additional 14 shares during the last quarter. Boston Advisors LLC boosted its position in HCA Healthcare by 0.6% in the first quarter. Boston Advisors LLC now owns 6,212 shares of the company’s stock worth $553,000 after buying an additional 37 shares during the last quarter. Capstone Asset Management Co. boosted its position in HCA Healthcare by 1.1% in the first quarter. Capstone Asset Management Co. now owns 7,083 shares of the company’s stock worth $630,000 after buying an additional 80 shares during the last quarter. Louisiana State Employees Retirement System boosted its position in HCA Healthcare by 0.6% in the second quarter. Louisiana State Employees Retirement System now owns 17,800 shares of the company’s stock worth $1,552,000 after buying an additional 100 shares during the last quarter. Finally, Eqis Capital Management Inc. boosted its position in HCA Healthcare by 2.8% in the first quarter. Eqis Capital Management Inc. now owns 3,800 shares of the company’s stock worth $338,000 after buying an additional 103 shares during the last quarter. Hedge funds and other institutional investors own 74.54% of the company’s stock.

HCA Healthcare Inc (NYSE HCA) opened at 78.87 on Monday. HCA Healthcare Inc has a 52-week low of $67.00 and a 52-week high of $91.03. The firm’s 50-day moving average price is $84.93 and its 200-day moving average price is $84.50. The company has a market cap of $29.60 billion, a price-to-earnings ratio of 10.57 and a beta of 0.67.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Tuesday, July 25th. The company reported $1.75 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $1.80 by $0.05. The business had revenue of $10.73 billion during the quarter, compared to analyst estimates of $10.76 billion. During the same period in the previous year, the business earned $1.66 EPS. HCA Healthcare’s revenue for the quarter was up 4.0% on a year-over-year basis. On average, equities analysts anticipate that HCA Healthcare Inc will post $7.20 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: This article was originally published by Daily Political and is the property of of Daily Political. If you are reading this article on another site, it was illegally stolen and republished in violation of U.S. and international trademark & copyright law. The legal version of this article can be viewed at https://www.dailypolitical.com/2017/08/07/hca-healthcare-inc-hca-is-hussman-strategic-advisors-inc-s-8th-largest-position.html.

A number of research firms have recently weighed in on HCA. BidaskClub lowered HCA Healthcare from a “hold” rating to a “sell” rating in a research note on Monday, July 24th. Zacks Investment Research lowered HCA Healthcare from a “hold” rating to a “sell” rating in a research note on Thursday, July 27th. Citigroup Inc. lowered their target price on HCA Healthcare from $89.00 to $87.00 and set a “neutral” rating for the company in a research note on Wednesday, July 26th. Morgan Stanley reissued an “equal weight” rating and issued a $88.00 target price (down previously from $90.00) on shares of HCA Healthcare in a research note on Wednesday, July 26th. Finally, Bank of America Corporation lowered HCA Healthcare from a “buy” rating to a “neutral” rating and lowered their target price for the company from $102.00 to $92.00 in a research note on Wednesday, July 26th. Two analysts have rated the stock with a sell rating, four have issued a hold rating and twelve have issued a buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average price target of $93.50.

In other HCA Healthcare news, SVP Jana Joustra Davis sold 54,689 shares of the business’s stock in a transaction that occurred on Tuesday, May 23rd. The stock was sold at an average price of $82.35, for a total transaction of $4,503,639.15. Following the completion of the transaction, the senior vice president now owns 107,892 shares in the company, valued at $8,884,906.20. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Jane D. Englebright sold 5,005 shares of HCA Healthcare stock in a transaction that occurred on Wednesday, May 10th. The shares were sold at an average price of $85.31, for a total transaction of $426,976.55. Following the sale, the senior vice president now directly owns 17,351 shares of the company’s stock, valued at approximately $1,480,213.81. The disclosure for this sale can be found here. Insiders have sold 151,424 shares of company stock valued at $12,787,290 in the last 90 days. Company insiders own 2.90% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare Inc and related companies with MarketBeat.com's FREE daily email newsletter.